A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Clinical trial NCT01943851 · COMPLETED
Trial details
- NCT number
- NCT01943851
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-14
- Primary completion
- 2020-04-30
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.